Anxiety Disorders Completed Phase 3 Trials for Methylphenidate (DB00422)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02153944Cognitive vs. Emotional Psychopharmacological Manipulations of Fear vs. AnxietyOther